Changlong Hou

A multi-institutional study to predict the benefits of DEB-TACE and molecular targeted agent sequential therapy in unresectable hepatocellular carcinoma using a radiological-clinical nomogram.

Jianyin Li, Jun Xie, Xingwan Wu, 2023, La Radiologia medica.